To learn if peripheral nerve stimulation (PNS) can help to improve pain in participants with CIPN.
Participants diagnosed with chronic (≥90 days duration) CIPN (due to either vinca alkaloids, taxanes, bortezomib, thalidomide, platinum-based compounds or ionizing irradiation) of the lower extremity, seen at Pain Management Center at MD Anderson Cancer Center
Participants reports baseline pain ≥ 4 (0-10 scale, NRS)
Participants between ages 18-85 years old
Participants who have completed chemotherapy within the previous year at the time of enrollment
Participants with cognitive dysfunction
Participants with recent history (<6 months) of drug or alcohol abuse
Participants with open skin lesion or undergoing antibiotic therapy for local for systemic infection
Participants with allergies to local anesthesia, steroids, or adhesives